# Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer

> **NCT00006486** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 335 (actual)

## Conditions studied

- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer

## Interventions

- **DRUG:** carboxyamidotriazole
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00006486
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** 2005-10
- **Final completion:** —
- **Target enrollment:** 335 (ACTUAL)
- **Last updated:** 2013-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006486, "Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00006486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*